NL8001752A - 4-amino-3-chinolinecarbonzuren en hun esters als antimaagzuur- en antimaagzweerverbinding. - Google Patents

4-amino-3-chinolinecarbonzuren en hun esters als antimaagzuur- en antimaagzweerverbinding. Download PDF

Info

Publication number
NL8001752A
NL8001752A NL8001752A NL8001752A NL8001752A NL 8001752 A NL8001752 A NL 8001752A NL 8001752 A NL8001752 A NL 8001752A NL 8001752 A NL8001752 A NL 8001752A NL 8001752 A NL8001752 A NL 8001752A
Authority
NL
Netherlands
Prior art keywords
ethyl
alkyl
methoxy
quinolinecarboxylate
amino
Prior art date
Application number
NL8001752A
Other languages
English (en)
Dutch (nl)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NL8001752A publication Critical patent/NL8001752A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8001752A 1979-03-26 1980-03-25 4-amino-3-chinolinecarbonzuren en hun esters als antimaagzuur- en antimaagzweerverbinding. NL8001752A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US2398179 1979-03-26
US12715380 1980-03-04
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
NL8001752A true NL8001752A (nl) 1980-09-30

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8001752A NL8001752A (nl) 1979-03-26 1980-03-25 4-amino-3-chinolinecarbonzuren en hun esters als antimaagzuur- en antimaagzweerverbinding.

Country Status (31)

Country Link
US (1) US4343804A (fr)
JP (1) JPH02117663A (fr)
AR (1) AR230268A1 (fr)
AT (1) AT372373B (fr)
AU (1) AU528388B2 (fr)
BR (1) BR8001779A (fr)
CA (1) CA1147338A (fr)
CH (1) CH644105A5 (fr)
DE (1) DE3011490A1 (fr)
DK (1) DK156056C (fr)
EG (1) EG15009A (fr)
ES (1) ES489887A0 (fr)
FI (1) FI77452C (fr)
FR (1) FR2452485B1 (fr)
GB (1) GB2047244B (fr)
GR (1) GR68006B (fr)
HK (1) HK67983A (fr)
IE (1) IE49577B1 (fr)
IL (1) IL59628A (fr)
IN (1) IN151446B (fr)
IT (1) IT1133079B (fr)
MX (1) MX6264E (fr)
NL (1) NL8001752A (fr)
NO (1) NO153927C (fr)
NZ (1) NZ193252A (fr)
PH (1) PH16416A (fr)
PL (1) PL125030B1 (fr)
PT (1) PT71008B (fr)
SE (1) SE435837B (fr)
SG (1) SG33683G (fr)
YU (1) YU41702B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (fr) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, leur utilisation et medicaments les contenant
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
ES2152989T3 (es) * 1993-08-10 2001-02-16 Black James Foundation Ligandos para los receptores de gastrina y cck.
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
SI2253620T1 (sl) 1998-09-29 2014-06-30 Wyeth Holdings Llc Substituirani 3-cianokinolini kot inhibitorji protein tirozin-kinaz
US6787534B2 (en) * 1999-12-28 2004-09-07 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
US6521618B2 (en) * 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
BRPI0406761A (pt) 2003-01-14 2005-12-20 Arena Pharm Inc Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
PL1606261T3 (pl) 2003-03-10 2010-04-30 Astrazeneca Ab Nowy sposób przygotowania roflumilastu
RS20060018A (en) * 2003-07-14 2007-12-31 Arena Pharmaceuticals Inc., Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
WO2011022216A1 (fr) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Dérivés de pyridine substitués, compositions pharmaceutiques et procédés d'utilisation pour traiter le stress oxydatif
EP4148045A1 (fr) 2010-01-27 2023-03-15 Arena Pharmaceuticals, Inc. Composés intermédiaires pour la préparation de l'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclopenta[b]indol-3-yl) acétique et de ses sels
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
MX2019005569A (es) * 2016-11-11 2019-09-05 Bayer Animal Health Gmbh Nuevos derivados de quinolina.
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US20210177827A1 (en) * 2017-10-25 2021-06-17 Children`S Medical Center Corporation Papd5 inhibitors and methods of use thereof
EP3790874B1 (fr) 2018-05-09 2023-03-15 Bayer Animal Health GmbH Dérivés de quinoléine anthelminthiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (fr) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
SG33683G (en) 1985-03-29
SE435837B (sv) 1984-10-22
AU5684880A (en) 1980-10-02
DE3011490A1 (de) 1981-03-12
IT1133079B (it) 1986-07-09
MX6264E (es) 1985-02-19
GR68006B (fr) 1981-10-26
AU528388B2 (en) 1983-04-28
NZ193252A (en) 1984-04-27
FI800910A (fi) 1980-09-27
BR8001779A (pt) 1980-11-18
IL59628A (en) 1983-06-15
GB2047244A (en) 1980-11-26
DK156056C (da) 1989-11-06
HK67983A (en) 1983-12-23
ATA156480A (de) 1983-02-15
PH16416A (en) 1983-09-29
FI77452B (fi) 1988-11-30
PL222993A1 (fr) 1981-01-30
EG15009A (en) 1985-03-31
FI77452C (fi) 1989-03-10
IE49577B1 (en) 1985-10-30
FR2452485B1 (fr) 1986-09-12
NO153927C (no) 1986-06-18
FR2452485A1 (fr) 1980-10-24
CA1147338A (fr) 1983-05-31
YU84480A (en) 1983-10-31
ES8103048A1 (es) 1981-02-16
YU41702B (en) 1987-12-31
GB2047244B (en) 1983-02-23
AT372373B (de) 1983-09-26
PT71008A (en) 1980-04-01
IT8067465A0 (it) 1980-03-26
NO800858L (no) 1980-09-29
ES489887A0 (es) 1981-02-16
JPH02117663A (ja) 1990-05-02
NO153927B (no) 1986-03-10
DK156056B (da) 1989-06-19
PL125030B1 (en) 1983-03-31
DE3011490C2 (fr) 1988-12-22
DK128380A (da) 1980-09-27
CH644105A5 (fr) 1984-07-13
US4343804A (en) 1982-08-10
IE800605L (en) 1980-09-26
SE8002292L (sv) 1980-09-27
IN151446B (fr) 1983-04-23
AR230268A1 (es) 1984-03-01
PT71008B (en) 1981-06-25
IL59628A0 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
NL8001752A (nl) 4-amino-3-chinolinecarbonzuren en hun esters als antimaagzuur- en antimaagzweerverbinding.
EP0310950B1 (fr) Quinoléines intermédiaires pour la synthèse des 1H-imidazo[4,5-c]quinoléines et 1H-imidazo[4,5-c]quinoléine-4-amines
EP0637300B1 (fr) Quinazolines anti-proliferatives
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
HU217623B (hu) Eljárás kondenzált tieno- és pirrolo [3,2-c]piridin-2-karbonsav-származékok valamint e vegyületeket tartalmazó gyógyászati készítmények előállítására
CZ302896A3 (en) Condensed bicyclic thiophenone compound, process of its preparation, its use, antagonistic preparation, conception control preparation and menorrhoeal cycle control preparation
JP2005502662A (ja) ホスホジエステラーゼ阻害剤としての１−アルキルまたは１−シクロアルキルトリアゾロ［４，３−ａ］キナゾリン−５−オン類
SK3192003A3 (en) Xanthine phosphodiesterase V inhibitors, process for their preparation, pharmaceutical composition comprising same and their use
DE2740588A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten
US8349854B2 (en) Salts of 4-aniline quinazoline derivative
PL150841B1 (en) Purine compounds.
ITMI941494A1 (it) Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
AU2702799A (en) Phenanthroline derivatives
CS217997B2 (en) Method of making the new derivatives of the pyrimidine
KR870000279B1 (ko) 피리도 [1,4] 벤조디아제핀 및 [2-[(니트로피리디닐) 아미노]페닐] 아릴메타논의 제조방법
EP1057829A1 (fr) Dérivés de la pyrimidine condensés et compositions pharmaceutiques les contenant
KR840000768B1 (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르의 제조방법
CA2125681A1 (fr) Derives 4-amino-3-acylquinolines et leur utilisation comme inhibiteurs de la secretion acide gastrique
US6242444B1 (en) Compounds and pharmaceutical compositions containing the same
CA1161757A (fr) Acides 4-amino-3-quinoline-carboxyliques et leurs esters, composes anti-secretions et anti-ulceres
CS216527B2 (cs) Způsob výroby 4-amino-3-chinolinkarboxylových kyselin a jejich esterů
EP0550007A2 (fr) Dérivés de l'eseroline ayant une activité anti-cholinesterase, procédé pour leur préparation et compositions pharmaceutiques les contenant
DD148776A5 (de) Verfahren zur herstellung neuer phenanthrolinderivate
JPH03264585A (ja) イミダゾキノロン誘導体

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed